close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorHealthcare

32.63 -0.18

Strong Buy

Price update 12 gru 2025, 19:33 UTC

BuySell

Overview

Share price change

24h

Current

Min

32.11

Max

32.86

Key metrics

By Trading Economics

Income

66M

-35M

Sales

70M

71M

Profit margin

-49.028

Employees

143

EBITDA

66M

-34M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.24% upside

Market Stats

By TradingEconomics

Market Cap

888M

3B

Previous open

32.81

Previous close

32.63

News Sentiment

By Acuity

50%

50%

187 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 gru 2025, 23:58 UTC

Acquisitions, Mergers, Takeovers

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

DJ

Read

11 gru 2025, 23:56 UTC

Earnings

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

DJ

Read

11 gru 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

DJ

Read

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

DJ

Read

11 gru 2025, 21:50 UTC

Earnings

Costco Same-Store Sales, Membership Fees Rose in 1Q

DJ

Read

11 gru 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

11 gru 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

DJ

Read

11 gru 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

DJ

Read

11 gru 2025, 23:31 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

DJ

Read

11 gru 2025, 22:48 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

DJ

Read

11 gru 2025, 22:35 UTC

Earnings

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

DJ

Read

11 gru 2025, 22:30 UTC

Earnings

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

DJ

Read

11 gru 2025, 22:09 UTC

Acquisitions, Mergers, Takeovers

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

DJ

Read

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

DJ

Read

11 gru 2025, 22:05 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

DJ

Read

11 gru 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

DJ

Read

11 gru 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

11 gru 2025, 21:39 UTC

Earnings

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

DJ

Read

11 gru 2025, 21:39 UTC

Earnings

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

DJ

Read

11 gru 2025, 21:38 UTC

Earnings

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

DJ

Read

11 gru 2025, 21:37 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

DJ

Read

11 gru 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

DJ

Read

11 gru 2025, 21:34 UTC

Acquisitions, Mergers, Takeovers

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

DJ

Read

11 gru 2025, 21:29 UTC

Acquisitions, Mergers, Takeovers

Dexus Aiming for Long-Term Holding of A$50M in Fund

DJ

Read

11 gru 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

DJ

Read

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus Expects to Introduce Additional Third-Party Equity in FY26

DJ

Read

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus: Third Party Investors to Contribute Remainder

DJ

Read

11 gru 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

DJ

Read

11 gru 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

DJ

Read

11 gru 2025, 21:25 UTC

Acquisitions, Mergers, Takeovers

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

25.24% upside

12 Months Forecast

Average 40.79 USD  25.24%

High 61 USD

Low 14.302 USD

Based on 15 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Based on 15 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

187 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,027.44

↑ +2.13%

JNJ

Johnson and Johnson

211.44

↑ +0.72%

ABBV

AbbVie Inc

223.45

↓-0.16%

UNH

UnitedHealth Group Inc

341.39

↑ +1.44%

AZN

AstraZeneca PLC ADR

89.79

↓-0.45%
help-icon Live chat